Thyrogen® Update: FDA Approves Widened Use

Genzyme announced on March 26, 2014, that the U.S. Food and Drug Administration (FDA) has approved the use of Thyrogen® (thyrotropin alfa for injection) in connection with a widened dose range of radioactive iodine (RAI) when used for thyroid remnant ablation. Genzyme’s announcement is here.